Analysts Release Price Targets And Ratings For Arbutus Biopharma Corp (ABUS)
Arbutus Biopharma Corp (NASDAQ:ABUS) concluded the trading at $3.29 on Friday, January 10 with a fall of -1.79% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $3.35 and 5Y monthly beta